FABRAZYME
Powder for concentrate for solution for infusion, 35mg
RxActive license
Active substance (INN)
agalsidase beta
Pharmaceutical form
Pharmaceutical formPowder for concentrate for solution for infusion
Strength35mg
PackagingUkupno 1 bočica staklena sa praškom za koncentrat za rastvor za infuziju u kartonskoj kutiji
ManufacturerGenzyme Ireland Limited, Ireland
Therapeutic groupAlimentary tract and metabolism (A16AB04)
Marketing authorization holderAMICUS PHARMA DOO PODGORICA
Authorization dateOctober 7, 2025
Source: CInMED register